Filing Flows › Nexgel (NXGL) › Q4 2025
Nexgel (NXGL) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 31, 2026
Nexgel (NXGL) reported revenue of $2.8M for the fourth quarter 2025 (Q4 2025), -8% from a year earlier and -5% from the quarter before. Operating margin was -43.4%, net loss $928K (33.2% of revenue).
Nexgel, Q4 2025: revenue $2.8M (-8% year over year), operating margin -43.4%, net loss $928K, operating cash flow $281K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | -5% | -8% |
| Operating profit | −$1.2M | — | — |
| Net earnings | −$928K | — | — |
| Operating cash flow | $281K | — | — |
What changed
Revenue was $2.8M in Q4 2025, down 8% year over year and down 5% from the previous quarter.
Gross margin was 29.3%, down 6.0 points from Q4 2024. Operating costs exceeded revenue by $1.2M, an operating margin of -43.4%. Operating expenses grew 6% against a revenue fall of 8%. The quarter ended with a net loss of $928K, wider than the previous quarter's $647K loss. Non-operating items added $286K, -31% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $281K. Non-cash charges added back $112K of depreciation and amortization and $156K of share-based compensation. Working capital and other items added $941K.
Questions
What was Nexgel's revenue in the fourth quarter 2025?
Nexgel (NXGL) reported revenue of $2.8M for the fourth quarter 2025 (Q4 2025), -8% from a year earlier and -5% from the quarter before.
Was Nexgel profitable in the fourth quarter 2025?
Operating loss was $1.2M (-43.4% of revenue) and net loss $928K.
Source: Nexgel 10-K on SEC EDGAR.